Literature DB >> 27835792

Intermittent fasting reduces body fat but exacerbates hepatic insulin resistance in young rats regardless of high protein and fat diets.

Sunmin Park1, Kyung Min Yoo2, Joo Suk Hyun2, Suna Kang2.   

Abstract

Intermittent fasting (IMF) is a relatively new dietary approach to weight management, although the efficacy and adverse effects have not been full elucidated and the optimal diets for IMF are unknown. We tested the hypothesis that a one-meal-per-day intermittent fasting with high fat (HF) or protein (HP) diets can modify energy, lipid, and glucose metabolism in normal young male Sprague-Dawley rats with diet-induced obesity or overweight. Male rats aged 5 weeks received either HF (40% fat) or HP (26% protein) diets ad libitum (AL) or for 3 h at the beginning of the dark cycle (IMF) for 5 weeks. Epidydimal fat pads and fat deposits in the leg and abdomen were lower with HP and IMF. Energy expenditure at the beginning of the dark cycle, especially from fat oxidation, was higher with IMF than AL, possibly due to greater activity levels. Brown fat content was higher with IMF. Serum ghrelin levels were higher in HP-IMF than other groups, and accordingly, cumulative food intake was also higher in HP-IMF than HF-IMF. HF-IMF exhibited higher area under the curve (AUC) of serum glucose at the first part (0-40 min) during oral glucose tolerance test, whereas AUC of serum insulin levels in both parts were higher in IMF and HF. During intraperitoneal insulin tolerance test, serum glucose levels were higher with IMF than AL. Consistently, hepatic insulin signaling (GLUT2, pAkt) was attenuated and PEPCK expression was higher with IMF and HF than other groups, and HOMA-IR revealed significantly impaired attenuated insulin sensitivity in the IMF groups. However, surprisingly, hepatic and skeletal muscle glycogen storage was higher in IMF groups than AL. The higher glycogen storage in the IMF groups was associated with the lower expression of glycogen phosphorylase than the AL groups. In conclusion, IMF especially with HF increased insulin resistance, possibly by attenuating hepatic insulin signaling, and lowered glycogen phosphorylase expression despite decreased fat mass in young male rats. These results suggest that caution may be warranted when recommending intermittent fasting, especially one-meal-per-day fasting, for people with compromised glucose metabolism.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Glucose tolerance; Glycogen phosphorylase; Hepatic insulin signaling; Insulin tolerance; Intermittent fasting

Mesh:

Substances:

Year:  2016        PMID: 27835792     DOI: 10.1016/j.jnutbio.2016.10.003

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  15 in total

1.  Intermittent fasting protects against the deterioration of cognitive function, energy metabolism and dyslipidemia in Alzheimer's disease-induced estrogen deficient rats.

Authors:  Bae Kun Shin; Suna Kang; Da Sol Kim; Sunmin Park
Journal:  Exp Biol Med (Maywood)       Date:  2018-01-07

2.  Transcriptome analysis reveals intermittent fasting-induced genetic changes in ischemic stroke.

Authors:  Joonki Kim; Sung-Wook Kang; Karthik Mallilankaraman; Sang-Ha Baik; James C Lim; Priyanka Balaganapathy; David T She; Ker-Zhing Lok; David Y Fann; Uma Thambiayah; Sung-Chun Tang; Alexis M Stranahan; S Thameem Dheen; Mathias Gelderblom; Raymond C Seet; Vardan T Karamyan; Raghu Vemuganti; Christopher G Sobey; Mark P Mattson; Dong-Gyu Jo; Thiruma V Arumugam
Journal:  Hum Mol Genet       Date:  2018-05-01       Impact factor: 6.150

Review 3.  Benefits, mechanisms, and risks of intermittent fasting in metabolic syndrome and type 2 diabetes.

Authors:  Lisandra Joaquim; Ana Faria; Helena Loureiro; Paulo Matafome
Journal:  J Physiol Biochem       Date:  2022-01-05       Impact factor: 4.158

4.  Early Time-Restricted Feeding Improves Insulin Sensitivity, Blood Pressure, and Oxidative Stress Even without Weight Loss in Men with Prediabetes.

Authors:  Elizabeth F Sutton; Robbie Beyl; Kate S Early; William T Cefalu; Eric Ravussin; Courtney M Peterson
Journal:  Cell Metab       Date:  2018-05-10       Impact factor: 27.287

Review 5.  Lysosomes Mediate Benefits of Intermittent Fasting in Cardiometabolic Disease: The Janitor Is the Undercover Boss.

Authors:  Kartik Mani; Ali Javaheri; Abhinav Diwan
Journal:  Compr Physiol       Date:  2018-09-14       Impact factor: 9.090

Review 6.  Flipping the Metabolic Switch: Understanding and Applying the Health Benefits of Fasting.

Authors:  Stephen D Anton; Keelin Moehl; William T Donahoo; Krisztina Marosi; Stephanie A Lee; Arch G Mainous; Christiaan Leeuwenburgh; Mark P Mattson
Journal:  Obesity (Silver Spring)       Date:  2017-10-31       Impact factor: 5.002

7.  Early Time-Restricted Feeding Improves 24-Hour Glucose Levels and Affects Markers of the Circadian Clock, Aging, and Autophagy in Humans.

Authors:  Humaira Jamshed; Robbie A Beyl; Deborah L Della Manna; Eddy S Yang; Eric Ravussin; Courtney M Peterson
Journal:  Nutrients       Date:  2019-05-30       Impact factor: 5.717

8.  Proteomic Analysis of Human Plasma during Intermittent Fasting.

Authors:  Dylan J Harney; Amy T Hutchison; Luke Hatchwell; Sean J Humphrey; David E James; Samantha Hocking; Leonie K Heilbronn; Mark Larance
Journal:  J Proteome Res       Date:  2019-04-01       Impact factor: 4.466

9.  Time-Restricted Feeding Improves Body Weight Gain, Lipid Profiles, and Atherogenic Indices in Cafeteria-Diet-Fed Rats: Role of Browning of Inguinal White Adipose Tissue.

Authors:  Samira Aouichat; Meriem Chayah; Souhila Bouguerra-Aouichat; Ahmad Agil
Journal:  Nutrients       Date:  2020-07-23       Impact factor: 5.717

10.  Intermittent Fasting for Twelve Weeks Leads to Increases in Fat Mass and Hyperinsulinemia in Young Female Wistar Rats.

Authors:  Ana Cláudia Munhoz; Eloisa Aparecida Vilas-Boas; Ana Carolina Panveloski-Costa; Jaqueline Santos Moreira Leite; Camila Ferraz Lucena; Patrícia Riva; Henriette Emilio; Angelo R Carpinelli
Journal:  Nutrients       Date:  2020-04-09       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.